Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00756977 · ClinicalTrials.gov registry record · Phase 3
BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy
A Phase 3 study, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 3
- Development phase
- 394
- Enrollment target
NCT00756977: Completed Phase 3 study, sponsored by Braintree Laboratories.
NCT00756977 is a Phase 3 study that has completed, run by Braintree Laboratories. The registered enrollment target is 394 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (49% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00756977, a Phase 3 study, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 394 participants
- Enrollment target
Study Summary
This is a randomized, parallel, multi-center, single-blind study, comparing BLI850 to an FDA approved bowel preparation in adult subjects undergoing colonoscopy.
Primary Outcome
Percentage of patients with a successful preparation (cleaning rated as "Good" or "Excellent"
Interventions
- DRUG BLI850
- DRUG polyethylene glycol 3350 based bowel preparation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 394 participants |
| Start Date | 2008-08 |
| Phase | Phase 3 |
What the finished NCT00756977 record still lists
NCT00756977 is an interventional study that assigns participants to a tested intervention. The registered 394 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (49% lower).
The record links to 0 conditions, and to 2 interventions - of which BLI850 is the first listed.
NCT00756977 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00756977 about?
NCT00756977 is a clinical study titled "BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy". This is a randomized, parallel, multi-center, single-blind study, comparing BLI850 to an FDA approved bowel preparation in adult subjects undergoing colonoscopy.
What is the current status of trial NCT00756977?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 394 participants. The study started on 2008-08.
What interventions are being tested in trial NCT00756977?
The interventions under investigation include: BLI850 (DRUG), polyethylene glycol 3350 based bowel preparation (DRUG).
Who is sponsoring clinical trial NCT00756977?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00756977's enrollment target sits among peer trials
394 967th of 2000 higher than 1,034 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06657924 · 394 participants · Phase 2
Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery
- NCT07225660 · 394 participants · NA
Hormonal Optimization: Late vs. Immediate Start After Discontinuation of Oral Contraceptives in Assisted Reproductive technologY (HOLIDAY)
- NCT07207369 · 395 participants · Phase 3
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars
- NCT05640999 · 393 participants · Phase 2
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia